Feasibility of myocardial dual-isotope perfusion imaging combined with gated single photon emission tomography for assessing coronary artery disease

Nuclear Medicine Communications

Volumn 23, Issue 1, 2002, Pages 19-29

  Fukuoka, S ^a   Maeno, M ^a   Nakagawa, S ^a   Fukunaga, T ^b   Yamada, H ^b   Eto, T ^b  

^a MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Coronary artery disease; Dual SPET; Gated SPET; Scatter correction

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIATION SCATTERING; RADIOISOTOPE VENTRICULOGRAPHY; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; FEASIBILITY STUDIES; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; RADIOPHARMACEUTICALS; STROKE VOLUME; THALLIUM RADIOISOTOPES; VENTRICULAR FUNCTION, LEFT;

EID: 0036188895     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200201000-00005     Document Type: Article

References (36)

1. Bailey IK, Griffith LS, Rouleau J, et al. Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation 1977; 55: 79-87.
2. Sinusas AJ, Shi Q, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664-671.
3. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
4. Jain D, Wackers FJ, Mattera J, et al. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
5. Nakajima K, Taki J, Shunke N, et al. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
6. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
7. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319.
8. 201Tl and regional myocardial blood flow. Circulation 1997; 96: 2332-2338.
9. Ichihara T, Ogawa K, Motomura N, et al. Compton scatter compensation using the triple-energy window method for single-dual-isotope SPECT. J Nucl Med 1993; 34: 2216-2221.
10. Nagamachi S, Jinnouchi S, Shimoshinbara S, et al. Modified triple energy window method for scatter correction - application to dual energy acquisition in myocardial SPECT. Radioisotopes 1998; 48: 177-187.
11. Heo J, Wolmer I, Kegel J, et al. Sequential dual-isotope SPECT imaging with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1994; 35: 549-553.
12. Kiat H, Germano G, Friedman J, et al. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. J Nucl Med 1994; 35: 542-548.
13. m-tetrofosmin. Nucl Med Commun 1998; 19: 119-126.
14. Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999; 137: 949-957.
15. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
16. Johnson JJ, Verdesca SA, Aude WY, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648.
17. DePuey EG, Parmett S, Ghesani M, et al. Comparison of Tc-99m sestamibi and Tl-201 gated perfusion SPECT. J Nucl Cardiol 1999; 6: 278-285.
18. Cwajg E, Cwajg J, He ZX, et al. Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography. J Nucl Med 1999; 40: 1857-1865.
19. Hashimoto J, Kubo A, Iwasaki R, et al. Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise. Eur J Nucl Med 1999; 26: 1541-1546.
20. Germano G, Erel J, Kiat H, et al. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997; 38: 749-754.
21. Tadamura E, Kudoh T, Motooka M, et al. Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging. J Am Coll Cardiol 1999; 33: 991- 997.
22. Toma DM, White MP, Mann A, et al. Influence of arm positioning on rest/stress technetium-99m labeled sestamibi tomographic myocardial perfusion imaging. J Nucl Cardiol 1999; 6: 163-168.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
24. Matsunari I, Fujino S, Taki J, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1961-1967.
25. Nicolai E, Cuocolo A, Acampa W, et al. Exercise-rest Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Tl-201 reinjection. J Nucl Cardiol 1999; 6: 270-277.
26. Dilsizian V, Rocco TP, Freedman NMT, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
27. Gutman J, Berman DS, Freeman M, et al. Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis. Am Heart J 1983; 106: 989-995.
28. Matsunari I, Fujino S, Taki J, et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol 1996; 77: 350-354.
29. Tamaki N, Yonekura Y, Mukai T, et al. Segmental analysis of stress thallium myocardial emission tomography for localization of coronary artery disease. Eur J Nucl Med 1984; 9: 99-105.
30. Tamaki N, Yonekura Y, Mukai T, et al. Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease. J Am Coll Cardiol 1984; 4: 1213-1221.
31. Ritchie JL, Bateman TM, Bonow RO, et al. Guideline for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association task force on the assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995; 25: 521-547.
32. Nichols K, DePuey EG, Rozanski A. Automation of gated tomographic left ventricular ejection fraction. J Nucl Cardiol 1996; 3: 475-482.
33. Nichols K, Tamis J, DePuey EG, et al. Relationship of gated SPECT ventricular function parameters to angiographic measurements. J Nucl Cardiol 1998; 5: 295-303.
34. 99mTc-tetrofosmin myocardial SPECT. J Nucl Med 1999; 40: 1693-1698.
35. Dilworth LR, Aisen AM, Mancini GBJ, et al. Determination of left ventricular volumes and ejection fraction by nuclear magnetic resonance imaging. Am Heart J 1987; 113: 24-32.
36. Paul AK, Hasegawa S, Yoshioka J, et al. Exercise-induced stunning continues for at least one hour: evaluation with quantitative gated single-photon emission tomography. Eur J Nucl Med 1999; 26: 410-415.